£5.0M
The funding round was led by PXN Ventures with participation from IQ Capital and Northern Gritstone.
Imperagen engineers better enzymes faster using quantum physics and artificial intelligence.
Imperagen is a Manchester-based techbio company that combines quantum physics, artificial intelligence, and automated laboratories to engineer enzymes for various industrial applications.
Guy Levy-Yurista
CEO
Andrew Almond
Researcher
Andrew Currin
Researcher
Tim Eyes
Researcher
The funding round was led by PXN Ventures with participation from IQ Capital and Northern Gritstone.